Flotegatide (18F)

Star0

DB18826InvestigationalSmall molecule

Flotegatide (18F): Overview.

Formula / weight: C₄₁H₆₀FN₁₃O₁₃ · 961.01 g/mol (avg)
Also known as: Cyclo(l-arginylglycyl-l-.alpha.-aspartyl-d-phenylalanyl-n6-(2,6-anhydro-7-deoxy-7-((2-(4-(3-(fluoro-18f)propyl)-1h-1,2,3-triazol-1-yl)acetyl)amino)-l-glycero-l-galacto-heptonoyl)-l-lysyl) · Flotegatide F-18

Resolves to

Compound

UNIIQ1MCS0I4BECAS1010702-75-6

Structure

InChIKeySDQRGILXNZSUMD-ABRGNQFASA-NSMILES

NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCCNC(=O)[C@H]2O[C@@H](CNC(=O)CN3C=C(CCC[18F])N=N3)[C@H](O)[C@@H](O)[C@H]2O)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O

What you can answer from here — as of June 25, 2024

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Flotegatide (18F), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account